Onderzoeker
Marc BUYSE
- Trefwoorden:Wiskunde
- Disciplines:Andere wiskunde en statistiek niet elders geclassificeerd
Affiliaties
- Data Science Instituut (Onderzoeksinstituut)
Lid
Vanaf1 jun 2019 → Heden - Wiskunde en statistiek (Departement)
Lid
Vanaf1 jan 2013 → Heden - Centrum voor Statistiek (Onderzoeksgroep)
Lid
Vanaf1 jan 1994 → Heden - Wetenschappen (Faculteit)
Lid
Vanaf1 okt 1991 → Heden - Toegepaste wiskunde (Departement)
Lid
Vanaf1 okt 2001 → 31 dec 2012 - Centrum voor Statistiek (Onderzoeksinstituut)
Lid
Vanaf1 okt 1994 → 31 mei 2019 - Wiskunde, natuurkunde, informatica (Afdeling)
Lid
Vanaf1 okt 1991 → 30 sep 2009
Publicaties
11 - 20 van 109
- The case against censoring of progression-free survival in cancer clinical trials - A pandemic shutdown as an illustration(2022)
Auteurs: Corinne Jamoul, Laurence Collette, Elisabeth Coart, Koenraad D'Hollander, Tomasz BURZYKOWSKI, Everardo D Saad, Marc BUYSE
- Does Central Monitoring Lead to Higher Quality? An Analysis of Key Risk Indicator Outcomes(2022)
Auteurs: Sylviane de Viron, Laura Trotta, William Steijn, Steve Young, Marc BUYSE
Pagina's: 295 - 303 - Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology(2022)
Auteurs: Richard M. Goldberg, Richard Adams, Marc BUYSE, Cathy Eng, Axel Grothey, Thierry Andre, Alberto F. Sobrero, Stuart M. Lichtman, Al B. Benson, Cornelis J. A. Punt, et al.
Pagina's: 819 - 828 - On the use of extreme value tail modeling for generalized pairwise comparisons with censored outcomes(2022)
Auteurs: Mickael De Backer, Catherine LEGRAND, Julien Peron, Alexandre Lambert, Marc BUYSE
Pagina's: 284 - 299 - Detection of Fraud in a Clinical Trial Using Unsupervised Statistical Monitoring(2022)
Auteurs: Sylviane de Viron, Laura Trotta, Helmut Schumacher, Hans-Juergen Lomp, Sebastiaan Hoppner, Steve Young, Marc BUYSE
Pagina's: 130 - 136 - Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long-term clinical endpoint(2022)
Auteurs: Leandro Garcia Barrado, Tomasz BURZYKOWSKI, Catherine LEGRAND, Marc BUYSE
Pagina's: 209 - 219 - Correcting the bias of the net benefit estimator due to right-censored observations(2021)
Auteurs: Julien Peron, Maryam Idlhaj, Delphine Maucort-Boulch, Joris Giai, Pascal Roy, Laurence Collette, Marc BUYSE, Brice Ozenne
Pagina's: 893 - 906 - Net benefit in the presence of correlated prioritized outcomes using generalized pairwise comparisons: A simulation study(2021)
Auteurs: Joris Giai, Delphine Maucort-Boulch, Brice Ozenne, Jean-Christophe Chiem, Marc BUYSE, Julien Peron
Pagina's: 553 - 565 - International consensus recommendations on key outcome measures for organ preservation after (chemo)radiotherapy in patients with rectal cancer(2021)
Auteurs: Emmanouil Fokas, Ane Appelt, Robert Glynne-Jones, Geerard Beets, Rodrigo Perez, Julio Garcia-Aguilar, Eric Rullier, J. Joshua Smith, Corrie Marijnen, Femke P. Peters, et al.
- The International Collaboration for Research methods Development in Oncology (CReDO) workshops: shaping the future of global oncology research(2021)
Auteurs: P Ranganathan, G Chinnaswamy, M Sengar, D Gadgil, S Thiagarajan, B Bhargava, CM Booth, Marc BUYSE, S Chopra, C Frampton, et al.
Pagina's: E369 - E376